YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C

BACKGROUND/AIMS: The aim of this study was to explore the association of a functional YKL-40 promoter polymorphism (rs4950928) with baseline disease stage, response to antiviral therapy, and risk of liver disease progression in a group of patients with chronic hepatitis C (CHC). METHODS: YKL-40 prom...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fontana, Robert J., Litman, Heather J., Dienstag, Jules L., Bonkovsky, Herbert L., Su, Grace, Sterling, Richard K., Lok, Anna S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3299849/
https://ncbi.nlm.nih.gov/pubmed/22103814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2011.02686.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky